Show simple item record

dc.contributor.authorValionyte, E
dc.contributor.authorBarrow, ER
dc.contributor.authorBaxter, CR
dc.contributor.authorLuo, S
dc.date.accessioned2024-05-01T10:29:16Z
dc.date.available2024-05-01T10:29:16Z
dc.date.issued2022-04-03
dc.identifier.issn1554-8627
dc.identifier.issn1554-8635
dc.identifier.urihttps://pearl.plymouth.ac.uk/handle/10026.1/22375
dc.description.abstract

SQSTM1/p62 is an autophagy receptor, forming droplets to sequester intracellular polyubiquitinated cargo and mediate its delivery for autophagic clearance. SQSTM1 droplets can function as platforms to allow the formation of autophagosomes at their surfaces. It would be interesting to understand how SQSTM1-droplet formation is regulated. We have shown that inflammatory toxicity induces SQSTM1 cleavage by CASP6 at a novel cleavage site, D256. The C-terminal cleavage product is unlikely to be functional, because it is hardly detectable, possibly due to its rapid turnover. The SQSTM1 N-terminal cleavage product (SQSTM1-N) exerts a dominant-negative effect on SQSTM1-droplet production, in turn attenuating SQSTM1 droplets-based autophagosome formation. Our study suggests that the CASP6-SQSTM1 axis negatively regulates SQSTM1 droplets-based autophagy under certain stress conditions.

dc.format.extent935-936
dc.format.mediumPrint-Electronic
dc.languageen
dc.publisherInforma UK Limited
dc.subjectAutophagosomes
dc.subjectautophagy
dc.subjectCASP6
dc.subjectliquid droplets
dc.subjectSQSTM1
dc.titleA dominant-negative regulatory mechanism of SQSTM1 droplets-based autophagy
dc.typejournal-article
dc.typeEditorial Material
plymouth.author-urlhttps://www.ncbi.nlm.nih.gov/pubmed/35188067
plymouth.issue4
plymouth.volume18
plymouth.publisher-urlhttp://dx.doi.org/10.1080/15548627.2022.2029672
plymouth.publication-statusPublished
plymouth.journalAutophagy
dc.identifier.doi10.1080/15548627.2022.2029672
plymouth.organisational-group|Plymouth
plymouth.organisational-group|Plymouth|Research Groups
plymouth.organisational-group|Plymouth|Faculty of Health
plymouth.organisational-group|Plymouth|Research Groups|Institute of Translational and Stratified Medicine (ITSMED)
plymouth.organisational-group|Plymouth|Research Groups|Institute of Translational and Stratified Medicine (ITSMED)|CBR
plymouth.organisational-group|Plymouth|REF 2021 Researchers by UoA
plymouth.organisational-group|Plymouth|Users by role
plymouth.organisational-group|Plymouth|Users by role|Current Academic staff
plymouth.organisational-group|Plymouth|REF 2021 Researchers by UoA|UoA01 Clinical Medicine
plymouth.organisational-group|Plymouth|Faculty of Health|Peninsula Medical School
plymouth.organisational-group|Plymouth|Users by role|Researchers in ResearchFish submission
plymouth.organisational-group|Plymouth|REF 2029 Researchers by UoA
plymouth.organisational-group|Plymouth|REF 2029 Researchers by UoA|UoA01 Clinical Medicine
dc.publisher.placeUnited States
dc.date.updated2024-05-01T10:29:15Z
dc.identifier.eissn1554-8635
dc.rights.embargoperiodforever
rioxxterms.versionofrecord10.1080/15548627.2022.2029672


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record


All items in PEARL are protected by copyright law.
Author manuscripts deposited to comply with open access mandates are made available in accordance with publisher policies. Please cite only the published version using the details provided on the item record or document. In the absence of an open licence (e.g. Creative Commons), permissions for further reuse of content should be sought from the publisher or author.
Theme by 
Atmire NV